Herpesvirus infection, glaucoma and ocular hypertension
https://doi.org/10.25700/NJG.2020.01.09
Abstract
In recent years, the stock of therapeutic agents for glaucoma treatment has been supplemented with new effective drugs. Despite this, only timely surgical intervention creates the conditions for the preservation of visual functions in patients with primary open-angle glaucoma. Surgical and laser interventions are the most frequently performed operations in primary glaucoma. But the risk of complications that lead to treatment efficacy decrease remains an important factor. Excessive scarring of the newly created intraocular fluid outflow pathways is one of the most frequent postoperative complications, which in 15-45% of cases leads to intraocular pressure level increase at different timepoints after surgery. Postoperative periods in different patients may have significant differences, despite a comparable clinical picture prior to the surgery.
Developing the criteria for predicting postoperative course, frequency and nature of complications, as well as a set of measures to prevent and eliminate the causes that lead to glaucoma surgery failure is a question of the utmost importance. Possible causes include chronic herpesvirus infection, whose role in glaucoma surgery outcome has not been sufficiently studied.
About the Authors
V. P. Erichev
Scientific Research Institute of Eye Diseases
Russian Federation
Med.Sc.D., Professor, Head of Glaucoma Department
Russian Federation
Med.Sc.D., Professor, Head of Glaucoma Department
E. H. Abdullaeva
Scientific Research Institute of Eye Diseases
Russian Federation
Abdullaeva E.H., Postgraduate student of Glaucoma Department
Russian Federation
Abdullaeva E.H., Postgraduate student of Glaucoma Department
References
1. Egorov E.A., Astakhov Yu.S., Erichev V.P. Rukovodstvo po glaukome dlya praktikuyushchih vrachej [Glaucoma guide for practitioners]. Moscow: GEOTAR-Media; 2015. 456 p. (In Russ.).
2. Erichev V.P., Egorov E.A. On the pathogenesis of primary open-angle glaucoma. Vestn oftalmol. 2014; 130(6):98-105. (In Russ.).
3. Neroev A.P. The pathogenesis of primary open-angle glaucoma: which concept is more legitimate? Ophthalmologicheskie vedomosti. 2008; 4:63-67. (In Russ.).
4. Sng C.C., Ang M., Barton K. Uveitis and glaucoma: new insights in the pathogenesis and treatment. Prog Brain Res. 2015; 221:243-269. doi:10.1016/bs.pbr.2015.06.008
5. Ayoade F.O. Herpes simplex 2018 [cited 2019]. Available from: https://emedicine.medscape.com/article/218580-overview.
6. Johnson R.W., Alvarez-Pasquin M.J., Bijl M., Franco E., Gaillat J., Clara J.G., Labetoulle M., Michel J.P., Naldi L., Sanmarti L.S., Weinke T. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015; 3(4):109-120. doi:10.1177/2051013615599151
7. Ragozzino M.W., Melton L.J., 3rd, Kurland L.T., Chu C.P., Perry H.O. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982; 61(5):310-316. doi:10.1097/00005792-198209000-00003
8. Johnson J.L., Amzat R., Martin N. Herpes Zoster Ophthalmicus. Prim Care. 2015; 42(3):285-303. doi:10.1016/j.pop.2015.05.007
9. Lau C.H., Missotten T., Salzmann J., Lightman S.L. Acute retinal necrosis features, management, and outcomes. Ophthalmology. 2007; 114(4):756-762. doi:10.1016/j.ophtha.2006.08.037
10. Chan E.W., Sun V., Eldeeb M., Kapusta M.A. Epstein-Barr virus acute retinal necrosis in an immunocompetent host. Retin Cases Brief Rep. 2018. doi:10.1097/ICB.0000000000000819
11. Oe C., Hiraoka M., Tanaka S., Ohguro H. Acute retinal necrosis associated with Epstein-Barr virus in a patient undergoing immunosuppressive therapy. Case Rep Ophthalmol. 2016; 7(1):195-201. doi:10.1159/000445372
12. Hershberger V.S., Hutchins R.K., Witte D.P., Schneider S., Harris R.E., McGonegle S.J. Epstein-Barr virus-related bilateral acute retinal necrosis in a patient with X-linked lymphoproliferative disorder. Arch Ophthalmol. 2003; 121(7):1047-1049. doi:10.1001/archopht.121.7.1047
13. Cunningham E.T., Jr., Downes K.M., Chee S.P., Zierhut M. Cytomegalovirus retinitis and uveitis. Ocul Immunol Inflamm. 2015; 23(5): 359-361. doi:10.3109/09273948.2015.1090820
14. Choi J.A., Kim K.S., Jung Y., Park H.Y., Park C.K. Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients. J Ophthalmic Inflamm Infect. 2016; 6(1):32. doi:10.1186/s12348- 016-0100-5
15. Anshu A., Tan D., Chee S.P., Mehta J.S., Htoon H.M. Interventions for the management of CMV-associated anterior segment inflammation. Cochrane Database Syst Rev. 2017; 8:CD011908. doi:10.1002/14651858.CD011908.pub2
16. Chee S.P., Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008; 146(6):883-889 e881. doi:10.1016/j.ajo.2008.09.001
17. Kandori M., Miyazaki D., Yakura K., Komatsu N., Touge C., Ishikura R., Inoue Y. Relationship between the number of cytomegalovirus in anterior chamber and severity of anterior segment inflammation. Jpn J Ophthalmol. 2013; 57(6):497-502. doi:10.1007/s10384-013-0268-2
18. Stoeger T., Adler H. "Novel" triggers of herpesvirus reactivation and their potential health relevance. Front Microbiol. 2018; 9:3207. doi:10.3389/fmicb.2018.03207
19. Suzich J.B., Cliffe A.R. Strength in diversity: Understanding the pathways to herpes simplex virus reactivation. Virology. 2018; 522:81-91. doi:10.1016/j.virol.2018.07.011
20. Kalogeropoulos D., Sung V.C. Pathogenesis of Uveitic Glaucoma. J Curr Glaucoma Pract. 2018; 12(3):125-138. doi:10.5005/jp-journals-10028-1257
21. Burcea M., Avram C.I., Stamate A.C., Malciolu R., Oprea S., Zemba M. [Ocular hypertension in herpes simplex keratouveitis]. Oftalmologia. 2014; 58(3):23-28.
22. Gulyamova M.D., Rizopulu A.P., Kamilov H.M., Fayzieva U.S., Umarova A.A., Garib F.Yu. Immunological characteristics of patients with chronic uveitis of herpetic and cytomegalovirus origin. Medicinskaya immunologia. 2005; 7(5-6):543-550. (In Russ.).
23. Choi J.A., Ju H.H., Kim J.E., Kim S.K., Jee D., Lee J., Park C.K., Paik S.Y. Transcriptional changes after herpes simplex virus type 1 infection in human trabecular meshwork cells. PLoS One. 2019; 14(5):e0217567. doi:10.1371/journal.pone.0217567
24. Townsend W.M., Kaufman H.E. Pathogenesis of glaucoma and endothelial changes in herpetic kerato-uveitis in rabbits. Am J Ophthalmol. 1971; 71(4):904-910. doi:10.1016/0002-9394(71)90265-0
25. Tektas O.Y., Heinz C., Heiligenhaus A., Hammer C.M., Luetjen-Drecoll E. Morphological changes of trabeculectomy specimens in different kinds of uveitic glaucoma. Curr Eye Res. 2011; 36(5):442-448. doi:10.3109/02713683.2011.566409
26. Sungur G.K., Hazirolan D., Yalvac I.S., Ozer P.A., Aslan B.S., Duman S. Incidence and prognosis of ocular hypertension secondary to viral uveitis. Int Ophthalmol. 2010; 30(2):191-194. doi:10.1007/s10792- 009-9305-z
27. Hoeksema L., Jansonius N.M., Los L.I. Risk factors for secondary glaucoma in herpetic anterior uveitis. Am J Ophthalmol. 2017; 181:55-60. doi:10.1016/j.ajo.2017.06.013
28. Ceballos E.M., Beck A.D., Lynn M.J. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma. 2002; 11(3):189-196. doi:10.1097/00061198-200206000-00005
29. Kaburaki T., Koshino T., Kawashima H., Numaga J., Tomidokoro A., Shirato S., Araie M. Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. Eye (Lond). 2009; 23(7):1509-1517. doi:10.1038/eye.2009.117-cme
30. Almobarak F.A., Alharbi A.H., Morales J., Aljadaan I. Intermediate and long-term outcomes of Mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma. J Glaucoma. 2017; 26(5):478-485. doi:10.1097/IJG.0000000000000653
31. Iwao K., Inatani M., Seto T., Takihara Y., Ogata-Iwao M., Okinami S., Tanihara H. Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma. 2014; 23(2):88-94. doi:10.1097/ IJG.0b013e3182685167
32. Kesav N., Palestine A.G., Kahook M.Y., Pantcheva M.B. Current management of uveitis-associated ocular hypertension and glaucoma. Surv Ophthalmol. 2019. doi:10.1016/j.survophthal.2019.12.003
33. Petrov S.Yu. The principles of modern glaucoma surgery according to the 4th edition of the European Glaucoma Guide. RMJ. Klinicheskaya ophthalmologia. 2017; 17(3):184-189. (In Russ.).
34. Kwon H.J., Kong Y.X.G., Tao L.W., Lim L.L., Martin K.R., Green C., Ruddle J., Crowston J.G. Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity. Clin Exp Ophthalmol. 2017; 45(5):472-480. doi:10.1111/ceo.12916
35. Carreno E., Villaron S., Portero A., Herreras J.M., Maquet J.A., Calonge M. Surgical outcomes of uveitic glaucoma. J Ophthalmic Inflamm Infect. 2011; 1(2):43-53. doi:10.1007/s12348-010-0012-8
36. Rotchford A.P., King A.J. Moving the goal posts definitions of success after glaucoma surgery and their effect on reported outcome. Ophthalmology. 2010; 117(1):18-23 e13. doi:10.1016/j.ophtha.2009.06.014
Review
For citations:
Erichev V.P., Abdullaeva E.H. Herpesvirus infection, glaucoma and ocular hypertension. National Journal glaucoma. 2020;19(1):61-68. (In Russ.) https://doi.org/10.25700/NJG.2020.01.09
Views:
790
Email this article 